PDCD1 and melanoma: However, the outcome of PD1–PD-L1 blockade therapy is not always in accordance with PD-L1 expression in melanoma [9, 15, 16], suggesting that PD-L1 expression alone is a poor predictor for response to PD1–PD-L1 blockade therapy.